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Abstract.  Glucocorticoid hormones regulate the post- 
translational maturation and sorting of cell surface and 
extracellular mouse mammary tumor virus (MMTV) 
glycoproteins in M1.54  cells, a stably infected rat 
hepatoma cell line. Exposure to monensin significantly 
reduced the proteolytic maturation and externalization 
of viral glycoproteins resulting in a stable cellular 
accumulation of a single 70,000-Mr glycosylated poly- 
protein (designated gp70). Cell surface- and intra- 
cellular-specific immunoprecipitations of monensin- 
treated cells revealed that gp70 can be localized to the 
cell surface only in the presence of 1 ~  dexametha- 
sone, while in uninduced cells gp70 is irreversibly se- 
questered in an intracellular compartment. Analysis of 
oligosaccharide processing kinetics demonstrated that 
gp70 acquired resistance to endoglycosidase H  with a 
half-time of 65 min in the presence or absence of hor- 
mone. In contrast, gp70 was inefficiently galactosylated 
after a 60-min lag in uninduced cells while rapidly ac- 
quiring this carbohydrate modification in the presence 
of dexamethasone. Furthermore, in the absence or 
presence of monensin, MMTV glycoproteins failed to 
be galactosylated in hormone-induced CR4 cells, a 
complement-selected sorting variant defective in the 
glucocorticoid-regulated compartmentalization of viral 
glycoproteins to the cell surface. Since dexamethasone 
had no apparent global effects on organelle morphol- 
ogy or production of total cell surface-galactosylated 
species, we conclude that glucocorticoids induce the 
localization of cell surface MMTV glycoproteins by 
"regulating a highly selective step within the Golgi 
apparatus after the acquisition of endoglycosidase 
H-resistant oligosaccharide side chains but before or 
at the site of galactose attachment. 
N 
EWLY synthesized glycoproteins destined for the plas- 
ma membrane or extracellular environment  undergo 
a  succession  of compartment-specific  processing 
reactions during transit through the cell (6, 8, 17, 30, 31, 45, 
52, 53, 62, 64). For example, different Golgi cisternae con- 
tain specific glycosyltransferases and glycosidases which se- 
quentially process the oligosaccharide portions of glycopro- 
tein substrates (6, 8, 24, 31, 48). In addition, the polypeptide 
backbone may be proteolytically cleaved at specific loci (52, 
64)  or,  for  some integral  membrane species,  selectively 
modified by acylation in the cis-Golgi (7, 37, 43, 56). The in- 
tracellular transport and processing of many cell surface gly- 
coproteins appears to proceed as part of the constitutive bulk 
flow movement of vesicle-compartmentalized  proteins (17). 
However, several studies have suggested that during the se- 
quential  vesicular budding and fusion processes between 
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various membrane organelles, constitutively transported spe- 
cies interact  with specific  recognition or carrier proteins 
which either retain polypeptide substrates in a given com- 
partment or redirect them to other routes or cellular loca- 
tions  (3,  14-16, 52).  For example,  132-microglobulin binds 
and selectively mediates the transport of histocompatibility 
leukocyte antigen to the cell surface (32, 44) while a heavy 
chain-binding protein appears to regulate the movement of 
immunoglobulin heavy chains between the rough endoplas- 
mic reticulum (RER) ~  and Golgi region (23). Carrier-medi- 
ated pathways have also been suggested to explain the differ- 
ential  intracellular  transport of two classes  of microvillus 
merabrane hydrolases  in  human intestinal  epithelial  cells 
(22) and the selective localization of  proteins to either the ap- 
ical or basolateral membranes of polarized ceils (38, 41, 46, 
61). Moreover, cell surface proteins within the same cell can 
undergo distinct processing reactions or display differential 
transport kinetics between certain organelles  (14, 52,  63). 
Thus, the precise control of entry into and through specific 
1. Abbreviations  used in this paper:  MMTV, mouse mammary tumor virus; 
RER, rough endoplasmic reticulum. 
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localize functioning glycoproteins to the cell surface; how- 
ever,  in most cases,  the  signaling  molecules that  regulate 
these processes have not been identified. 
By examining  the expression and  sorting of cell surface 
mouse mammary tumor virus (MMTV) glycoproteins, we 
have uncovered evidence for a steroid-regulated intracellular 
trafficking pathway that is expressed in hepatic-derived tis- 
sue (9-13,  21). Dexamethasone,  a synthetic glucocorticoid, 
regulates the posttranslational maturation and localization of 
a single glycosylated MMTV precursor polyprotein (Pr74 ~"v) 
in M1.54 cells, a MMTV-infected rat hepatoma (HTC) cell 
line (13, 21). One-dimensional V8 protease peptide mapping 
revealed that identical MMTV glycosylated precursor poly- 
proteins (Pr74  e"V) are initially  synthesized in dexamethasone- 
induced and uninduced cells (21). In a manner similar to the 
biosynthesis of MMTV glycoproteins in other systems (54), 
each newly synthesized precursor is intercalated in the RER 
membrane  and  contains  five endoglycosidase  H-sensitive 
("high mannose") oligosaccharides. Exposure to dexametha- 
sone redirects the posttranslational  expression of the glyco- 
sylated precursor  resulting  in the production of three new 
cell surface MMTV glycoproteins (gp78, gp70, and gp32) as 
well as an extracellular form of gp70. Both gp78 and gp70 rep- 
resent different glycosylated forms of the same polyprotein 
in that both contain  complex oligosaccharides  but gp78  is 
sialyated to a greater extent. During transit through the cell, 
one or both of these polyproteins is proteolytically cleaved 
into  an amino-terminal  fragment  (gp50)  and the carboxy- 
terminal portion (gp32). The amino-terminal fragment, gp50, 
is constitutively externalized and is the predominant MMTV 
glycoprotein in uninduced cells (9,  10,  12,  13). In the pres- 
ence of glucocorticoids,  all  of the viral  glycoproteins are 
transported in association with the vesicle membranes (20); 
however, only gp78, gp70, and gp32 are stably integrated into 
the plasma membrane and acquire a lipid modification (11). 
We  have  previously  reported  that  the  glucocorticoid- 
regulated trafficking of MMTV glycoproteins to the cell sur- 
face is a genetically distinct hormone response (10, 12) that 
requires receptor function and the de novo synthesis of cellu- 
lar encoded gene products (11, 21, 27). To further define the 
reactions  under  glucocorticoid control,  we used the well- 
characterized Na÷/K  ÷ ionophore, monensin (49), which has 
been shown to  disrupt  or  slow down certain  intracellular 
maturation and transport processes (18, 25, 33, 40, 58, 59). 
Monensin treatment simplified the overall pattern of MMTV 
protein maturation  by inhibiting  the proteolytic processing 
and externalization of the MMTV glycosylated polyprotein. 
These effects caused the  stable cellular accumulation  of a 
70,000-Mr  MMTV  glycoprotein  (gp70)  and,  therefore,  al- 
lowed an analysis of the sorting of a single viral substrate that 
is  destined  for  the  cell  surface  only  in  the  presence  of 
glucocorticoids.  By examining the kinetics of oligosaccha- 
ride processing of MMTV glycoproteins expressed in both 
wild-type hepatoma cells and a complement-selected sorting 
variant (10, 12, 27), we have localized a key glucocorticoid- 
regulated step in glycoprotein sorting to the Golgi region. 
Materials and Methods 
Materials 
All media and sera used for tissue culture were purchased from the Univer- 
sity of California, San Francisco Tissue Culture Facility.  L-[35S]Methionine 
(1,000 Ci/mmol), D-[2-3H]mannose  (16 ci/mmol), and [3H]sodium  borohy- 
dride  (10  ci/mmol)  were  obtained  from  Amersham  Corp.  (Arlington 
Heights, IL) and EN3HANCE from New England Nuclear (Boston, MA). 
Dexamethasone,  monensin,  and  galactose oxidase  were  procured  from 
Sigma Chemical Co. (St. Louis, MO), and Pansorbin and tunicamycin were 
acquired  from  Calbiocbem-Behring Corp.  (San  Diego,  CA  [La Jolla]). 
Agarose derivatized with castor bean lectin (Ricin 120) was purchased from 
P-L Biochemicals (Milwaukee, WI) and Pharmacia Fine Chemicals (Pis- 
cataway,  NJ),  and x-ray  film was obtained from Merry X-Ray  Chemical 
Corp. (Burlingame, CA). Rhodamine isothiocyanate-conjugated goat anti- 
rabbit IgG was purchased from Cappel Laboratories (Malvern, PA).  The 
anti-MMTV and preimmune sera (5) used in this study were generous gifts 
of L. L 1". Young and R. D. Cardiff (Department of Pathology, University 
of California, Davis). All other reagents were of  the highest available purity. 
Cells and Method of Culture 
M1.54  is a cloned cell line isolated from MMTV-infected rat populations 
of cultured  hepatoma  cells  (50);  selection of  its  complement-resistant 
derivative, CR4, has been described previously (10, 12, 13). Both cell lines 
were propagated as monolayers in DME and radiolabeled with [3~S]methi- 
onine in methionine-free medium as described (21, 29). Where indicated, 
cell cultures were treated with 1 p_M monensin and glucocorticoid-treated 
cells received 1 IxM dexamethasone. 
Pulse-Chase Experiments 
Monolayer cultures were preincubated with 1 p.M monensin for 1 h before 
treatment in the presence or absence of 1 IxM dexamethasone. After 18 h, 
the cells were incubated for 40 min in methionine-free medium and then 
pulsed labeled with 50 p.Ci/ml  [35Slmethionine  for 10 min. After quickly 
rinsing the cells several times in PBS, the radiolabel was chased by incubat- 
ing the cells in medium supplemented with 0.5% FCS and unlabeled me- 
thionine (0.3  mg/ml); appropriate concentrations of dexamethasone and 
monensin were present in the medium throughout both incubation periods. 
After 0, 30, 60, 90, 120, and 240 min of chase, cell monolayers were washed 
three times with ice-cold PBS, dislodged from the plates in 1 mM EDTA, 
10 mM Tris-HCl, pH 7.5, in PBS, and centrifuged at 600 g for 10 rain. The 
cell pellets were solubilized in 1% Triton X-100, 0.5% deoxycholate, 5 mM 
EDTA, 250 mM NaC1, 25 mM Tris-HC1,  pH 7.5, and then applied to ricin 
affinity columns or digested with endoglycosidase H as described below. For 
the dexamethasone into chase experiment, uninduced ceils were pulse ta- 
beled with 50  ixCi/ml  [35S]methionine  for  1 h,  rinsed in  PBS,  and  in- 
cubated with unlabeled methionine for 8 h in the presence or absence of 
1 pM dexamethasone. The pulse-chase experiment using [2-3H]mannose 
was accomplished as previously described (11). 
Steady-State Incorporation of  Radiolabeled Material 
and Recovery  of  Cellular and Secreted Fractions 
Cells pretreated with or without 1 p.M monensin for 1 h were incubated in 
the presence or absence of 1 laM dexamethasone for 16 h and subsequently 
radiolabeled in 30 ~tCi/ml [35Slmethionine  for 4 h. Appropriate combina- 
tions of dexamethasone and monensin were present throughout the radio- 
labeling period. The secreted fractions were harvested by centrifugation of 
the culture medium at 2,000 g  for 10 rain; the resulting supernates were 
brought to 1% Triton X-100, 0.5% deoxycholate, and 5 mM EDTA just be- 
fore immunoprecipitation. The cell monolayers were washed three times in 
ice cold PBS and incubated with MMTV antibodies as described below for 
the cell surface immunoprecipitations. 
Galactose Oxidase-mediated  Labeling of  Cell 
Surface-associated Glycoproteins 
24-h dexamethasone-induced  and uninduced M1.54 ceils were washed three 
times  with  PBS  and  incubated  with  15  U  galactose  oxidase  in  1  ml 
PBS/plate, for 5 rain at 37°C (28). Cell monolayers were washed extensively 
with PBS, placed on ice for 2 min, and then gently overlayed with 1 ml PBS 
containing 1 mCi [3H]sodium  borohydride. Labeling was allowed to pro- 
ceed for 5 rain on ice, and the cells were then washed twice with PBS con- 
taining 10% horse serum to absorb the excess radiolabel, followed by two 
additional  washes with PBS.  Cells were then harvested, detergent solu- 
bilized,  and  radiolabeled glycoproteins were  fractionated in  SDS-poly- 
acrylamide gels. 
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The expression of metabolically radiolabeled plasma membrane MMTV 
polypeptides were selectively examined by modifications of the method of 
Krangel et al. (32)  as previously described (21). Intact cells were first in- 
cubated with 4 ~tl polyclonal anti-MMTV or preimmune sera in 1 ml PBS 
at 4°C for 15 min and then washed once with 10% horse serum in media, 
three times with PBS, and finally harvested. Ceils were detergent solubi- 
lized as described above and the cell extracts incubated with l0 lal of 10% 
(wt/vol) Pansorbin (fixed Staphylococcus  aureus) for 5 rain to immunoad- 
sorb the surface-associated antigen-antibody complexes. After centrifuga- 
tion to recover the Pansorbin-pelletable (cell surface) material, more anti- 
bodies (8 lxI of 1:10 dilution of serum) and Pansorhin (10 ~tl of 10% wt/vol) 
were added to the supernates to monitor expression of the intracellular 
MMTV proteins. Immunoprecipitations were continued as described below. 
lmmunoprecipitation of  MMTV Glycoproteins, 
SDS Gel Electrophoresis, and Fluororadiography 
Immunoprecipitations of cellular and secreted fractions were carried out 
with either anti-MMTV glycoprotein antibodies, total anti-MMTV antibod- 
ies, or with preimmune serum, using a  highly sensitive low background 
Pansorbin assay previously described (26, 47). Final Pansorbin (S. aureus) 
pellets were solubilized in 25 p.1 SDS gel sample buffer (reference 34) and 
incubated with 5 p.l of 0.5 M dithiothreitol (DTT) at 100°C for 2 rain. After 
a 3-min Eppendorf  centrifugation, the supernataut fractions were subjected 
to electrophoresis in SDS-polyacrylamide gels (42) containing 10% acryl- 
amide.  Proteins were subsequently fixed and stained by incubation over- 
night with 0.4% Coomassie Brilliant Blue then destained in 10 % acetic acid 
for 5  h.  Gels were impregnated with EN3HANCE for 1 h,  incubated in 
water for 1 h, dried under vacuum at 60°C, and analyzed by fluorography 
on Kodak RP-Royal  X-Omat film at  -70°C. 
Endoglycosidase H Digestion 
Sensitivity to the endoglycosidase H was assayed as previously described 
(19). Briefly, immunoprecipitated MMTV glycoproteins were released from 
antibody-S, aureus complexes in 30 ~tl  1% SDS at room temperature for 
10 min, and the supernatant fractions added to 150 ~t1100 mM sodium citrate 
buffer, pH 5.5, containing 80 mU/ml endoglycosidase H. Control incuba- 
tions did not receive any enzyme. After 24 h at 37°C, the reactions were 
terminated by adding immunoprecipitation (solubilization) buffer contain- 
ing MMTV antibody. The antibody-antigen complexes were then precipi- 
tated with S.  aureus and fractionated in SDS-polyacrylamide gels. 
Ricin-Agarose Column Chromatography 
Ricin-agarose was poured to a bed volume of 0.5 ml and washed extensively 
with 0.1% Triton X-100, 150 mM NaCI,  10 mM Tris, pH 7.5 (ricin-binding 
buffer). Solubilized cell extracts were diluted to a final concentration of  0.1% 
Triton X-100 by the addition of I0 mM Tris-HCl, pH 7.5,  150 mM NaC1, 
and  applied to  the  ricin-agarose column,  washed extensively in  ricin- 
binding buffer; ricin-bound material was eluted with 3 % galactose in ricin- 
binding buffer (19). Bound and nonbound fractions were immunoprecipi- 
rated and analyzed by SDS-PAGE. 
Indirect lmmunofluorescence 
M1.54 and CR4 cells were transferred to polylysine-coa~d coverslips (4) 
and cultured overnight in the presence of 1 IsM dexamethasone with and 
without 1 ~vl monensin, washed several times with PBS, and fixed by in- 
cubating with 3.7 % formaldehyde in PBS for 20 rain at room temperature. 
After washing extensively in PBS containing 10 mM glycine, the cells were 
incubated for 30 rain on ice with 1 ml of an antibody solution containing 
80 I,  tl of a  I:10 dilution of anti-MMTV antibody,  100 p.1 of BSA solution 
(50 mg/ml), and 820 gl of PBS. The antibody solution was then aspirated 
off, cultures washed several times in PBS-glycine and then incubated with 
500 ~tl PBS containing 120 Ixl of a  1:100 dilution of rhodamine-conjugated 
goat anti-rabbit IgG After 30 min on ice, the coverslips were washed four 
times in PBS-glycine  and then mounted on slides in 90% glycerol, 10% Tris- 
HCI (1130 mM), pH 7.5 (55). Mounted slides were either examined immedi- 
ately by fluorescence microscopy or stored at -20"C before visualization. 
Transmission Electron Microscopy 
Monolayer cultures of MI.54 and CR4 cells were treated with the indicated 
combinations of 1 ~I dexamethasone and 1 WVI monensin for 24 h and then 
fixed in 2 % glutaraldehyde in 0.05 M cacodylate, pH 7.4, for 30 min. After 
rinsing in buffer, monolayers were then immersed in a solution of  cacodylate 
containing 0.5%  OsO4, 0.8% K~e(CN)6 at 4°C for 15 min, followed by 
another buffer rinse,  as described by McDonald  (39).  Cells were then 
placed in a 0.15 % solution of tannic acid in buffer for 1 min and rinsed with 
buffer.  The monolayers were then immersed in a 2 % solution of aqueous 
uranyl acetate for 120 min. Cells were infiltrated after dehydration and em- 
bedded in Medcast-Araldite 6005 (Pelco Corp., Tustin, CA) as previously 
described (2). 0.8-~tm sections were placed on copper grids, and stained 
with uranyl acetate and lead citrate before analysis using a Philips 300 trans- 
mission electron microscope. 
Assay of  Membrane-associated Galactosyl 
Transferase Activity 
Cells were treated in the presence or absence of 1 la-M  dexamethasone for 
24 h, harvested, incubated in a  hypotonic swelling buffer (20 mM KCI, 
20 mM Tris-HCl, pH 7.2) at 4°C for 10 min, and broken by homogenization 
in a  Dounce glass homogenizer (Kontes Glass Co., Vinetand, NJ).  Post- 
nuclear supernates were isolated by centrifugation at 2,000 g for 10 min and 
the microsomal membranes pelleted after centrifugation at 32,000 rpm for 
90 min at 4°C in a Ti40 rotor.  The microsomal membranes were resus- 
pended in 1 ml of 0.25 M sucrose, I mM EDTA, 10 mM Tris-HCl, pH 7.0, 
aspirated through a 23-gauge needle 10 times, and fractionated on a 65-15 % 
sucrose gradient by centrifugation for 16 h at 25,000  rpm in an SW28 rotor; 
2.5-ml fractions were collected, diluted to 14 ml in the hypotonic swelling 
buffer,  and repelleted by centrifugation at 32,000 rpm in a Ti40 rotor for 
I h at 4°C. The resulting pellets were resuspended in 0.25 M sucrose, 1 mM 
EDTA, 10 mM Tris-HCl, pH 7.0, by aspiration through a 23-gauge needle 
and  assayed for galactosyl transferase activity  using UDP-[3H]galactose 
and ovomucoid as an acceptor glycoprotein (51). The peak galactosyl trans- 
ferase activity migrated in all gradients between 0.7 and 0.95 M  sucrose. 
Results 
Monensin-mediated Expression of  a Single MMTV 
Glycosylated Polyprotein and Its Selective Localization 
to the Cell Surface in a Glucocorticoid- 
dependent Manner 
Dexamethasone-induced and uninduced M1.54 cells were in- 
cubated in  the absence  or presence  of monensin (1  I~NI) 
before and throughout a 4-h radiolabeling period with [35S]- 
methionine.  By  adding  anti-MMTV  antibodies  to  intact 
cells,  we  were  able  to  design  immunoprecipitations that 
directly  distinguish  [35S]methionine-labeled  cell  surface- 
associated polypeptides from intracellular MMTV polypep- 
tides expressed in the same sample of cells. Extracellular vi- 
ral glycoproteins were analyzed by immunoprecipitation of 
the conditioned culture media. Consistent with our previous 
results (10, 12, 21), several new cell surface-associated (gp78, 
gp70, and gp32; Fig. 1, lane E vs. G) and extracellular (gp70) 
MMTV glycoproteins (lane I vs. K) and two new intracellu- 
lar viral phosphoproteins (p35 and p24; lane A vs. C) were 
uniquely expressed in dexamethasone-treated M1.54  cells. 
Exposure to monensin selectively altered the pattern of ex- 
pressed  MMTV  proteins.  The  predominant  intracellular 
viral glycoprotein detected in both hormone-induced (lane 
D) and uninduced (lane B) cells treated with monensin was 
a stable form of a 70,000-Mr polyprotein (designated gp70). 
The  Pr74 species  shown  in  this  gel  represents  the phos- 
phorylated precursor polyprotein which is encoded by the 
viral gag gene and is selectively immunoprecipitated with 
anti-phosphoprotein antibodies (12, 29). Even though intra- 
cellular gp70 was clearly observed in the presence or absence 
of hormone (lanes B and D), its translocation to the cell sur- 
face was  observed only after exposure to dexamethasone 
(lane H vs. F). 
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sion of intracellular, cell surface, and extra- 
cellular MMTV proteins. Dexamethasone- 
induced (lanes C, D, G, H, K, and L) and 
uninduced (lanes A, B, E, F, I, and J) M1.54 
cells were treated in the presence (lanes B, 
D, F,, H, J, and L) or absence (lanes A, C, 
E, G, L and K) of monensin, radiolabeled 
with  [3SS]methionine, and  the  expression 
of intracellular  (lanes A-D),  cell  surface 
(E-H),  and  secreted (l-L)  viral  proteins 
were  analyzed  by  immunoprecipitation, 
as described in the text. After fractionation 
in  SDS-polyacrylamide  gels,  radioactive 
protein  bands  were  visualized by fluoro- 
graphic display. The molecular weight stan- 
dards  are  phosphorylase  b  (97,000 Mr), 
BSA (68,000 Mr), bovine gamma globulin 
(50,000 Mr), ovalbumin  (43,000 Mr), glycer- 
aldehyde phosphate dehydrogenase (36,000 
M~), and trypsin inhibitor (20,000 M,). 
Densitometric analysis of the autoradiograph (Fig. 1, lane 
G vs. H) revealed that in hormone-induced cells, ionophore 
treatment caused an ,~20-fold accumulation of gp70 at the 
cell surface. This striking accumulation may have resulted in 
part from its failure to be exfoliated into the extracellular en- 
vironment (Fig. 1, lane Kvs. L). Consistent with this notion, 
pulse-chase  analysis  of dexamethasone-induced  cells  re- 
vealed that gp70 reaches the cell surface in the presence or 
absence of ionophore, but its subsequent release into the cul- 
ture media was selectively blocked in monensin-treated cells 
(data not shown). It is important to point out that hormone- 
induced M1.54 ceils not exposed to monensin externalize a 
70,O00-M,  species  (gp70),  although  both  a  78,000-  and 
70,O00-M,  species (gp78 and gp70)  are detected at the cell 
surface (Fig. 1 and reference 21). I.n a manner similar to the 
shedding effect  normally observed in MMTV-expressing cell 
lines (54), externalized gp70 may be derived from one of the 
plasma membrane-associated polyproteins. 
The ionophore-mediated accumulation of cell surface gp70 
in hormone-induced cells was further confirmed by an ,'~20- 
fold increase in [t2~I]gp70 labeled by lactoperoxidase iodina- 
tion of intact cells and by an increased sensitivity to anti- 
MMTV  antibody-directed complement-mediated cytolysis 
(data not shown). Thus, in the presence of monensin, gp70 
accumulated  at  the  cell  surface  only  in  glucocorticoid- 
treated cells, whereas, in uninduced cells, gp70 remained in 
an unidentified intracellular fraction. Regardless of the pre- 
cise mechanism, exposure to monensin provided the ability 
to follow the intracellular sorting of a  single well-defined 
Figure 2. Endoglycosidase H digestion of gp70 expressed in gluco- 
corticoid-induced and uninduced MI.54 cells. (a) Dexamethasone- 
treated (lower gel)  and untreated  (upper gel)  M1.54 ceils were 
pulsed labeled with [35S]methionine  for 5 min and incubated with 
excess unlabeled methionine for the indicated chase periods. Cells 
were solubilized in detergents and duplicate aliquots immunopre- 
cipitated with anti-MMTV glycoprotein antibodies. The viral gly- 
coproteins were released from Pansorbin in 1% SDS, digested with 
(lanes B, D, F, H, J, and L) and without (lanes A, C, E, G, I, and 
K) endoglycosidase H, and fractionated in SDS-polyacrylamide 
gels as described in the text. (b) The percent of gpT0 containing 
endoglycosidase H-resistant  oligosaccharides (Endo H-resistant 
gp70/total gp70) through the pulse-chase time course (b) was quan- 
titated by scanning the fluorogram of Endo H-digested  samples 
with a soft laser densitometer, e,  -DEX; A,  +DEX. 
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glucocorticoid-induced  and uninduced cells. (a) Through the same 
pulse-chase  time  course  as  described  in  Fig.  2,  detergent- 
solubilized extracts from hormone-induced  (lower gel) and unin- 
duced (uppergel) M1.54 cells were applied to ricin affinity columns 
and galactose-containing glycoproteins eluted with 3 % galactose as 
described in the text. Pass-through (PT) and ricin-binding (B) ma- 
terial  were immunoprecipitated  with  anti-MMTV  glycoproteins 
and fractionated in SDS-polyacrylamide  gels. (b) The percent gp70 
bound to ricin (B/[PT + B] x  100%) through the pulse-chase time 
course (b) was quantitated by soft laser densitometry of the fluoro- 
grams,  o,  -  DEX;  A,  +DEX. 
Figure 4.  Analysis  of galac- 
tose-containing  cell  surface 
glycoproteins  in  glucocorti- 
coid-induced  and  uninduced 
M1.54 cells. MI.54 cells were 
treated  in the presence  (lane 
B) or absence (lane A) of 1 IxM 
dexamethasone  for 24  h  and 
the galactose residues of cell 
surface  glycoproteins labeled 
in intact cells by the galactose 
oxidase and NaB[3H]4 proce- 
dure described in the text. Ra- 
diolabeled  cell  extracts  were 
fractionated in SDS-polyacryl- 
amide gels and galactose-con- 
raining species  visualized  by 
fluorography.  The  molecular 
weight standards are the same 
as Fig.  1 with the addition of 
conalbumin  (76,000 Mr). 
substrate, gp70, which can be used to explore the hormone- 
inducible process that mediates the localization of cell sur- 
face glycoproteins. 
Analysis of  MMTV Glycoprotein Transport by 
Oligosaccharide-processing Kinetics in Glucocorticoid- 
induced and Uninduced Cells 
To define the approximate intracellular site where glucocor- 
ticoids  affect glycoprotein trafficking,  the  oligosaccharide 
processing state of gp70 was assayed through a pulse-chase 
time course.  Resistance to endoglycosidase H  was used to 
monitor the transport of gp70  from the RER to the medial 
Golgi (8,  24,  31, 48).  Dexamethasone-induced M1.54 cells 
were treated with monensin for 16 h and radiolabeled for l0 
min with [35S]methionine  followed by additional incubation 
in the presence of excess unlabeled methionine. At the indi- 
cated times, radiolabeled MMTV glycoproteins were immu- 
noprecipitated and incubated in the presence or absence of 
endoglycosidase H. As shown in Fig. 2 (fluorographs of im- 
munoprecipitated gp70), in both dexamethasone-treated and 
-untreated cells, virtually all of gp70 acquired at least one en- 
doglycosidase H-resistant oligosaccharide side chain with a 
65-min half time (Fig.  2  b).  Thus,  hormone treatment did 
not affect the apparent rate by which gp70 is transported from 
the RER to the medial Golgi region. 
Transport of gp70 between the medial and trans cisternae 
of the Golgi was studied through the same chase points, by 
examining the rate and extent of galactose attachment (6,  8, 
48).  Detergent-solubilized extracts  from monensin-treated 
cells were applied to ricin-derivatized agarose affinity col- 
unms and the galactosylated glycoproteins that bound ricin 
eluted with 3 % galactose. Both the nongalactosylated mate- 
rial that passed through the column (PT) and bound (B) frac- 
tions  were assayed for gp70  by  immunoprecipitation with 
anti-MMTV glycoprotein antibodies (Fig.  3 a). The galac- 
tosylation of gp70 was strikingly altered in dexamethasone- 
induced cells.  Densitometric quantitation of the proportion 
of gp70 that bound ricin revealed that in uninduced cells gp70 
inefficiently acquired galactosyl residues after an initial  1-h 
lag,  whereas  in  hormone-treated cells,  >70%  of gp70  ac- 
quired  this  sugar modification  with  no  apparent  time lag 
(Fig. 3 b). Thus, the efficient galactosylation of gp70 can be 
strongly  correlated  with  its  entry  into  a  glucocorticoid- 
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by Glucocorticoid-induced and Uninduced Wild-type and 
Variant Cell Lines 
Galactosyl transferase 
Cell line  Dexamethasone  specific activity 
nmol/30 rnin per mg* 
M 1.54  -  4.02 
M1.54  +  2.85 
CR4  -  4.99 
CR4  +  3.32 
* Posmuclear supernates from dexamethasone-treated and untreated cells were 
centrifuged at  100,000  g  for  90  min  and  the  resulting microsomal  pellets 
resuspended and applied to a 65-15% sucrose gradient. Galactosyl transferase 
activity was  monitored  by  the  formation  of  [3H]galactose-ovomucoid from 
UDP-[~H]galactose  in each gradient fraction and  the  specific activity of the 
peak fractions calculated. 
regulated transport route within the Golgi complex and its 
subsequent localization to the cell surface. 
Most likely, attachment of galactose residues occurs distal 
to,  or  at,  the  actual  hormone-induced  regulatory  step  in 
MMTV glycoprotein transport.  Importantly, however, sev- 
eral lines of evidence suggest that dexamethasone does not 
affect general competence for the production of galactosyl- 
ated  glycoproteins.  The  expression  of total  galactosylated 
glycoproteins at the cell surface was assayed by incubation 
of intact ceils with galactose oxidase followed by reduction 
of the oxidized galactose residues with NaB[3H]4.  As shown 
in Fig. 4, the identical array of cell surface galactose-labeled 
glycoproteins were detected in hormone-induced and unin- 
duced cells not exposed to monensin. Thus, glucocorticoids 
appear to regulate the trafficking of a restricted subset of gly- 
coprotein substrates since many glycoproteins are constitu- 
tively localized to the. cell surface.  Consistent with this re- 
suit, the specific activity of galactosyl transferase in membrane 
fractions enriched in Golgi vesicles was similar in hormone- 
induced and uninduced cells (Table I). Furthermore, dexa- 
methasone treatment had no effect on the extent and rate of 
[3H]galactose  attachment  to  total  cellular  glycoproteins 
(data not shown). These experiments were accomplished in 
the absence of monensin although ionophore treatment per 
se did not significantly affect galactosyl transferase activity 
and the synthesis of galactosylated cellular and cell surface 
glycoproteins, nor did it affect the efficient galactosylation of 
gp70 in the presence of hormone (data not shown). 
Trafficking of  gp70 Proceeds into a "Dead End" 
Pathway in Uninduced Cells 
Conceivably, in uninduced cells, gp70 may be sequestered in 
a cell compartment which prevents its subsequent compart- 
mentalization to the cell surface, or it may be transported up 
to and no further than the glucocorticoid-regulated reaction. 
To test these possibilities, uninduced cells not treated with 
monensin were pulse labeled with  [35S]methionine  for  1 h 
and incubated with excess unlabeled methionine for 8 h ei- 
ther in the presence or absence of dexamethasone.  An  8-h 
chase period was used since 4-h exposure to hormone is re- 
quired  for expression of gpT0 at the cell surface (21). The 
presence of intracellular and cell surface MMTV glycopro- 
reins were analyzed by immunoprecipitation.  As shown in 
Figure 5. Analysis of [35S]methionine-labeled intraceilular and cell 
surface MMTV glycoproteins pulse labeled in uninduced cells and 
chased in the presence or absence of dexamethasone.  Uninduced 
M1.54 cells were radiolabeled with [35S]methionine for 1 h (lanes 
A and D) and incubated with excess unlabeled methionine in the 
presence (lanes C and F) or absence (lanes B and E) of 1 IxlVl  dexa- 
methasone for 8 h. Cell surface (lanes D-F) and intracellular (lanes 
A-C) MMTV glycoproteins were analyzed by immunoprecipitation 
as described  in the text. Immunoprecipitated  material were frac- 
tionated  in  SDS-polyacrylamide  gels  and  radiolabeled  proteins 
were visualized  by fluorographic  display. The molecular  weight 
standards are described in Fig.  1 with the addition of I]-galactosi- 
dase (120,000 Mr). 
Fig. 5, gp70 failed to be detected at the cell surface both with 
or without the addition of dexamethasone during the chase 
incubation (lanes F and E) and remained in an intracellular 
fraction (lanes C and B). The reduced levels of gp70 detected 
after an  8-h chase  relative to the  pulse point  most likely 
reflect proteolytic  processing  into  gp50  and  gp32.  These 
results  suggest that  in  uninduced  cells,  newly synthesized 
gp70 is sequestered in an intracellular compartment that does 
not allow its subsequent transport to the cell surface even af- 
ter hormonal exposure. 
Analysis of  Cellular Morphology by Electron Microscopy 
To examine potential effects of dexamethasone treatment on 
subcellular morphology, cross sections of hormone-induced 
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treated with the following combinations of 1 I.tM monensin and 1 ~  dexamethasone for 24 h: (A) no additions; (B) dexamethasone; (C) 
monensin; and (D) dexamethasone and monensin. Monolayers were fixed, poststained with osmium ferricyanide, and analyzed by transmis- 
sion electron microscopy as described in the text. G, Golgi cisternae; D, dilated vacuole; E  Golgi-associated vesicles; M, mitochondria; 
and R,  rough endoplasmic reticulum. Bars,  1 lain. and uninduced monolayer cultures of M1.54 cells, treated in 
the  presence or  absence  of monensin,  were analyzed by 
transmission electron microscopy. Perinuclear areas shown 
in Fig.  6 revealed that the stacking and vesicularization of 
Golgi-like vesicles were similar in the presence or absence 
of hormone (Fig.  6, B  vs.  A and D  vs.  C).  In the absence 
of ionophore, the Golgi region typically observed with (Fig. 
6 B) and without (Fig. 6 A) hormone treatment consisted of 
cisternae surrounding a dilated vacuole; occasional flattened 
cisternae without an accompanying vacuole were also ob- 
served.  Thus,  under  conditions  in  which  dexamethasone 
treatment affects the intracellular sorting of MMTV glyco- 
proteins, horfnone treatment had no detectable effects on the 
Golgi morphology. As expected (59),  monensin increased 
the relative number and  sizes of vesicular structures dis- 
persed within the perinuclear area (Fig. 6, C and D vs. A and 
B). In general, most of the Golgi elements are replaced by 
dilated  vacuoles  with  some  normal-appearing  Golgi  ele- 
ments. Importantly, dexamethasone treatment had no addi- 
tional affects on general vesicular structure. 
Localization and Galactosylation of  MMTV 
Glycoproteins in the Sorting Variant CR4 
In a previously characterized sorting variant, CR4, the over- 
all pattern of MMTV glycoprotein maturation in the pres- 
ence of dexamethasone was strikingly similar to uninduced 
wild-type M1.54 cells (12). Visualization by electron micros- 
copy revealed that  the  overall  subcellular  morphology of 
variant CR4 is virtually identical to wild-type M1.54 cells 
after dexamethasone and/or monensin treatment (data not 
shown).  Indirect  immunofluorescence  demonstrated  that 
dexamethasone-treated  wild-type M1.54  cells  displayed a 
clearly  visible  capping  of anti-MMTV  antibody-directed 
fluorescence in the presence or absence of monensin indica- 
tive of cell surface-associated viral antigens (Fig. 7, b and 
d).  In  contrast,  hormone-induced CR4  failed to  localize 
MMTV glycoproteins to the cell surface either in the pres- 
ence or absence of monensin (Fig. 7, fand h).  Under these 
conditions,  immunofluorescent  labeling  of  intracellular 
membrane-associated MMTV glycoproteins is clearly visi- 
ble in detergent permeabilized cells (data not shown). 
The kinetics of gp70 galactosylation in hormone-induced 
CR4  treated  with  monensin  was  monitored by  the  ricin- 
binding assay through an identical pulse-chase time course 
as described for Fig. 3. As shown in Fig. 8, hormone-induced 
CR4 competently produced gp70 and, like uninduced wild- 
type cells (Fig. 3), this glycoprotein remained in an intracel- 
lular fraction and.ungalactosylated. The galactosylation of 
MMTV  glycoproteins  was  also  monitored  in  wild-type 
M1.54  and  variant  CR4  cells  not  exposed to  ionophore. 
Hormone-induced cells were pulse labeled with [2-3H]man  - 
nose for 10 min and incubated with excess unlabeled man- 
nose for 90 min. Analysis of galactosylation by ricin binding 
revealed that after 90 min, ,x60% of MMTV glycoproteins 
bind to ricin and are eluted with 3 % galactose (Fig. 9, lane 
G  vs.  E);  the three major ricin-binding species are gp78, 
gp70, and gp50 (Fig. 9, lane G). In contrast, most MMTV 
glycoproteins remain ungalactosylated in CR4 (Fig. 9, lane 
O  vs.  M).  As  expected,  the  RER  form  of  the  viral- 
glycosylated polyprotein synthesized in wild-type (lane A) 
and variant (lane I  ) cells during the 10-min pulse failed to 
bind ricin since galactoslyation is a Golgi-mediated reaction. 
Figure 7. Immunofluorescence analysis ofceU surface MMTV gly- 
coproteins.  M1.54 and  CR4  cells  were  plated onto  polylysine- 
coated coverslips, incubated in the presence (c, d, g, and h) or ab- 
sence (a, b, e, and  f) of 1 IzM monensin and treated with 1 laM dexa- 
methasone for 16 h. Cells were fixed in formaldehyde  and incubated 
sequentially with anti-MMTV  antibodies and rhodamine-conju- 
gated goat anti-rabbit IgG as described in the text. Populations of 
cells were examined by both phase (a, c, e, and g) and fluorescence 
(b, d, f, and h) microscopy. Bar, 30 ~m. 
The level of membrane-associated galactosyl transferase 
activity (Table I) and bulk expression of galactosylated gly- 
coproteins (data not shown) were unaffected in CR4. Impor- 
tantly,  in a manner similar to hormone-induced M1.54 cells, 
dexamethasone-treated CR4 produces MMTV glycoproteins 
with  endoglycosidase  H-resistant  oligosaccharides  (12) 
demonstrating that the RER-to-Golgi transport of MMTV 
glycoproteins in CR4 was not defective. Taken together, our 
hormonal and genetic results suggest that MMTV glycopro- 
teins enter the early Golgi cisternae by a constitutive route 
and  are  routed  by a  glucocorticoid-regulated step  in  the 
Golgi before or at the site of galactose attachment. 
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matography of gpT0 expressed 
in  glucocorticoid-induced, 
monensin-treated  CR4  cells. 
Dexamethasone-treated  CR4 
cells were pulsed labeled with 
[35S]methionine for 5 rain and 
incubated  with  excess  unla- 
beled methionine for the indi- 
cated  chase  periods.  Deter- 
gent-solubilized extracts were 
applied to  ricin  affinity col- 
umns  and  galactose-contain- 
ing glycoproteins eluted with 
3%  galactose as described in 
the text. Pass-through (P) and 
ricin-binding  (B)  material  were 
immunoprecipitated  with anti- 
MMTV  glycoproteins  and  frac- 
tionated  in  SDS-polyacryl- 
amide gels. 
Figure  9.  Ricin affinity chro- 
matography of MMTV glyco- 
proteins  expressed  in  dexa- 
methasone-induced wild-type 
cells and a  sorting variant in 
the absence of monensin. Cul- 
tures of M1.54  and CR4 cells 
were exposed to  1 IJaM dexa- 
methasone for 24 h  and then 
pulse  labeled  with  100  I.tCi 
[2:H]mannose  for  20  min 
followed by further incubation 
in the presence of excess unla- 
beled  mannose  for  90  min; 
dexamethasone  was  present 
throughout  the  experiment. 
Cellular fractions  were  har- 
vested after the  pulse  (lanes 
A-D  and  l-L)  and  90-rain 
chase (lanes E-H and M-P). 
Detergent-solubilized  extracts 
were applied to ricin affinity 
columns  and  galactose-con- 
taining  glycoproteins  eluted 
with 3 % galactose as described 
in the text. Pass-through (PT) 
and ricin-binding (B) material 
were immunoprecipitated with 
anti-MMTV glycoprotein an- 
tibodies (lanes A, C, E, G, I, 
K, M, and O) or preimmune 
serum (lanes B, D, F,, H, J, L, 
N, and P) and fractionated in 
SDS-polyacrylamide  gels. The 
molecular  weight  standards 
are the same as described in 
Figs. 1, 4, and 5 with the addi- 
tion of phosphorylase a (94,000 
Mr),  aldolase  (40,000  Mr), 
and chymotrypsinogen (25,000 
M,). 
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By monitoring the kinetics and efficiency of MMTV glyco- 
protein oligosaccharide-processing in wild-type and variant 
hepatoma cells, we have uncovered a glucocorticoid-regu- 
fated step in the trafficking of membrane glycoproteins that 
occurs within the medial or trans-Golgi cisternae. For some 
of our studies, we exploited the Na+/K  ÷ ionophore monen- 
sin, which simplified the normally complex maturation pat- 
tern  of MMTV  glycoproteins.  Similar  to  other  reported 
membrane proteins (25, 58, 60), monensin significantly re- 
duced the proteolytic processing of the MMTV glycosylated 
polyproteins and additionally prevented their externaliza- 
tion. Under these conditions, a stable cellular 70,000-Mr vi- 
ral  glycoprotein  (gp70) accumulated  in  both  hormone- 
induced and uninduced wild-type cells but was localized to 
the cell surface only after exposure to dexamethasone. Thus, 
despite the known global effects on cellular morphology and 
protein transport (18, 40,  58), treatment with monensin al- 
lowed a  selective analysis of the glucocorticoid-regulated 
trafficking  of  relatively  high  concentrations  of  a  single 
plasma membrane-directed substrate. Dexamethasone treat- 
ment did not simply overcome a monensin-mediated block 
in protein trafficking  within wild-type M1.54 cells, since in the 
presence or absence of ionophore MMTV glycoproteins are 
transported to the cell surface only after hormone induction. 
Furthermore, ionophore treatment did not alter the pheno- 
type of a sorting variant, CR4, which fails to galactosylate 
and transport MMTV glycoproteins to the cell surface in the 
presence of dexamethasone. 
Other  investigators have  suggested that the trans-Golgi 
network,  which  is  morphologically contiguous  with  the 
trans-cisternae of  the Golgi region, provides a regulatory site 
for the differential trafficking of secreted and lysosomal pro- 
teins (17). In nonpolarized cells, certain membrane-associ- 
ated proteins appear to be constitutively transported from 
this  network  (17). Recently,  an  epithelial  organelle,  the 
vacuolar apical  compartment, was described  in polarized 
MDCK cells which selectively stored apically destined pro- 
teins (61). In addition, for some cell surface (and secreted) 
proteins, a  rate-limiting step in intracellular transport has 
been  observed  in the  RER-to-Golgi translocation process 
(14, 35, 36, 63). The novel feature of our results is the detec- 
tion of a glucocorticoid-induced regulatory site within the 
Golgi complex after the acquisition of endo-I~-N-acetylglu- 
cosaminidase H-resistant oligosaccharides but before or at the 
attachment site of galactose that alters the intracellular sorting 
of membrane-associated glycoproteins.  Glucocorticoids do 
not affect the bulk localization of cell surface-associated gly- 
coproteins containing galactose  or the expression  of galac- 
tosyl transferase activity (Fig. 4 and Table I) suggesting that 
a unique subset of glycoproteins is apparently transported 
through the glucocorticoid-regulated pathway while most 
membrane species are routed through a nonregulated or con- 
stitutive pathway. The precise mechanism is unknown and 
glucocorticoids may regulate any one of many types of cellu- 
lar trafficking reactions that include an attenuation of an ac- 
tual branchpoint in glycoprotein sorting, a selective stimula- 
tion in the vesicular export rate from certain Golgi cisternae, 
or a processing activity that acts on MMTV glycoproteins. 
In  hormone-induced  cells,  MMTV  glycoproteins  are 
efficiently transported to the cell surface, while in uninduced 
cells these same substrates  enter constitutively  into a  dead 
end compartment from which they cannot be transported to 
the cell surface even after hormone treatment. Part of the 
specificity of this phenomenon most likely results from the 
actions of vesicle- or organelle-associated "sorting carriers,' 
analogous  to  mannose-6-phosphate  receptors  (8,  57)  and 
132-microglobulin (32,  44)  that bind and help segregate or 
retain specific glycoprotein substrates into specific intracel- 
lular compartments or through certain sorting routes. Given 
current concepts in steroid hormone action (1, 65), glucocor- 
ticoids might directly induce specific sorting receptors that 
act within the Golgi complex to actively direct gtycoproteins 
into an intracellular route, which delivers them to the cell 
surface,  or by regulating the synthesis of blocking activities 
that selectively  prevent  certain glycoproteins from entering 
the  constitutive  route.  Perhaps  processing  activities  that 
modify MMTV glycoproteins such that they acquire a specific 
sorting signal may also be under hormonal control. In this re- 
gard, we have previously reported that the MMTV glycosyl- 
ated precursors  synthesized in hormone-induced and unin- 
duced cells are structurally identical (21) suggesting that the 
steroid-mediated modification of gp70 is an unlikely event. 
Whatever the mechanism, the hormone-regulated sorting of 
viral glycoproteins required de novo RNA synthesis (21, 26) 
indicating the  selective involvement of newly synthesized 
glucocorticoid-inducible components.  Furthermore,  these 
regulated components appear mutable since MMTV glyco- 
proteins failed to be translocated to the cell surface and were 
inefficiently galactosylated into dexamethasone-treated vari- 
ant CR4 cells (Figs.  7-9). 
This study has shown that glucocorticoids regulate the in- 
tracellular sorting of MMTV glycoproteins destined for the 
cell surface;  the hormone-inducible event does not affect 
RER-to-Golgi  transport  but  facilitates  the  trafficking  of 
specific glycoproteins through the Golgi region. The modu- 
lation of even a single posttranslational event could strongly 
influence the functional expression of many hepatoma cell 
glycoprotein products. In principle, such a pathway may be 
used to acutely regulate the trafficking of multiple, perhaps 
functionally related, sets of proteins during the development 
and function of normal liver.  In fact, a series of fusion ex- 
periments have revealed that normal rat hepatocytes func- 
tionally complement the defect in variant CR4 confirming 
that normal liver expresses components of the glucocorti- 
coid-regulated  trafficking pathway  (26).  Through  further 
characterization of MMTV glycoprotein trafficking in both 
wild-type and variant cell  lines,  it should be possible to 
define the precise posttranslational reactions that are under 
control of glucocorticoid hormones as well as identify the 
other cellular encoded glycoprotein substrates of this pathway. 
We thank Karen S. Brown, Sharon Amacher, Emily J. Platt, Anne K. Vallerga, 
and Sandra D. Winguth for their helpful suggestions  and critical reading of 
this manuscript. We also thank Aileen K. Kim and Christina Cheng for their 
skillful typing of this manuscript and John Underhill for his superb photog- 
raphy. 
This research was supported by a grant from the National Science Foun- 
dation (DCB-8616446) awarded to G. L. Firestone; the electron microscopy 
experiments were also supported by a Young Investigator Award from the 
National Institutes of Health (AM 38310) awarded to G. W. Aponte. G. L_ 
Firestone is a recipient of a National Science Foundation Presidential Young 
Investigator Award (DCB-8351884). O. K. Haffar and N. J. John were post- 
doctoral  trainees  supported  by  a  National  Research Service Grant  (CA 
The Journal of Cell Biology, Volume 106,  1988  1472 09041) awarded  by the National Institutes of Health, Department of Health 
and Human Services.  In the later stages of this work, N. J. John was sup- 
ported by a postdoctoral  fellowship from the American Cancer Society, Inc. 
(PF-2892).  D. A. Bravo was supported by a Minority Access to Research 
Careers  Fellowship  (GM  10274) awarded  by  the  National  Institutes of 
Health,  Department of Health and Human Services. 
Received for publication 12 August 1987, and in revised  form 22 December 
1987. 
References 
1. Anderson, LH. 1984. The effect of steroid hormones on gene transcription. 
In Biological Regulation and Development.  Hormone Action. Vol. 3B. 
R. F.  Goldberger  and  K.  R.  Yamamoto,  editors.  Plenum  Publishing 
Corp., New York.  169-212. 
2. Aponte, G. W., D. Gross, and T. Yamada.  1985. Capillary orientation of 
rat pancreatic D-cell processes: evidence for endocrine release of somato- 
statin. Am. J.  Physiol.  249:G599-G606. 
3. Blobel, G.  1980. Intracellular protein topogenesis. Proc. Natl. Acad. Sci. 
USA. 77:1496-1500. 
4.  Bottenstein, J., and G. Sato.  1980. Fibronectin and polylysine requirement 
for proliferation  of neuroblastoma  cells  in defined medium.  Exp. Cell 
Res.  129:361-366. 
5. Cardiff, R. D., M. J.  Puentes, L. J. T.  Young, G. H. Smith, Y. A. Ter- 
amoto, B. W. Altrack, and T. S. Pratt. 1978. Serological and biochemical 
characterization of the mouse mammary tumor virus with localization of 
pl0.  Virology. 85:157-167. 
6. Dunphy, W. G., andJ. E. Rothman. 1985. Compartmentalization organiza- 
tion of the Golgi stack.  Cell. 42:13-21. 
7. Dunphy, W. G., E. Fries,  L. J. Urbani,  and J. E. Rothman.  1981. Early 
and late functions associated with the Golgi apparatus reside in distinct 
compartments.  Proc. Natl. Acad.  Sci. USA. 78:7453-7457. 
8.  Farquhar,  M.  G.  1985. Process  in unraveling pathways of Golgi traffic. 
Annu.  Rev. Cell Biol. 1:447-488. 
9. Firestone, G. L. 1988. Glucocorticoid regulation of protein processing and 
compartmentalization.  In  Endocrine  Genes:  Analytical  Methods,  Ex- 
perimental Methods, and Selected Systems. Y.-F. C. Lau, editor. Oxford 
University  Press,  New York.  97-117. 
10.  Firestone, G. L., and K. R. Yamamoto. 1983. Two classes of mutant mam- 
mary  tumor  virus-infected  HTC  cell  with  defects  in  glucocorticoid- 
regulated gene expression.  Mol. Cell. Biol. 3:149-160. 
1  I. Firestone, G. L., N. J. John, O. K. Haffar, and P. W. Cook.  1987. Genetic 
evidence that the steroid-regulated  trafficking of cell surface glycopro- 
teins in rat hepatoma cells is mediated by glucocorticoid inducible cellular 
components. J.  Cell Biochem.  35:271-284. 
12.  Firestone, G. L., N. J. John, and K. R. Yamamoto.  1986. Glucocorticoid- 
regulated glycoprotein maturation in wild-type and mutant rat cell lines. 
J.  Cell Biol. 103:2323-2331. 
13.  Firestone, G. L., F. Payvar,  and K. R. Yamamoto.  1982. Glucocorticoid 
regulation  of  protein  processing  and  compartmentalization.  Nature 
(Lond. ).  300:221-225. 
14.  Fitting,  T., and D. Kabat.  1982. Evidence for a glycoprotein "signal" in- 
volved in transport between subcellular organelles. J. Biol. Chem. 257: 
14011-14017. 
15. Garoff, H. 1985. Using recombinant DNA techniques to study protein tar- 
geting in the eucaryotic cell. Annu. Rev.  Celt Biol. 1:403-445. 
16.  Gebhart, A. M., and R. W. Ruddon. 1986. What regulates secretion of non- 
stored proteins by eukaryotic  cells? Bioessays.  4:213-218. 
17. Griffiths, G., and K. Simons.  1986. The trans Golgi Network:  sorting at 
the exit site of the Golgi complex.  Science  (Wash. DC). 234:438-443. 
18. Griffiths, G., P. Quinn, and G. Warren.  1983. Dissection of  the Gotgi com- 
plex. I. Monensin inhibits the transport of viral membrane proteins from 
medial to trans-Golgi cisternae in baby hamster kidney cells infected with 
Semliki Forest virus. J.  Cell Biol. 96:835-850. 
19.  Haffar, O. K., C. E. Edwards,  and G. L. Firestone.  1986. Regulation of 
alphas-acid glycoprotein  externalization  and intracellular  accumulation 
in glucocorticoid-induced  rat hepatoma cells. Arch. Biochem.  Biophys. 
246:449-459. 
20.  Haffar, O. K., C. E. Edwards, and G. L. Firestone.  1986. Protein glycosy- 
lation regulates the externalization of two distinct classes of glucocorti- 
cold-induced  glycoproteins  in  rat  hepatoma  cells.  Biochim. Biophys. 
Acta.  884:520-530. 
21. Haffar, O. K., A. K. Vallerga,  S. A. Marenda,  H. J. Witchel, and G. L. 
Firestone.  1987. Glucocorticoid-regulated  compartmentalization of cell 
surface-associated glycoproteins in rat hepatoma cells: evidence for an in- 
dependent response that requires receptor function and de novo RNA syn- 
thesis. Mol. Cell. Biol. 7:1508-1517. 
22.  Hauri,  H.-P., E. E. Sterchi, D. Bienz, J. A. M. Fransen,  and A. Marxer. 
1985.  Expression  and intracellular  transport  of microvillus  membrane 
hydrolases in human intestinal epithelial cells. J. CellBiol.  101:838-851. 
23.  Hendershot,  L., D. Bole, G. Kohler,  and J. F.  Kearney.  1987. Assembly 
and secretion  of heavy chains that do not associate posttranslationally 
with  immunoglobulin heavy  chain-binding  protein.  J.  Cell Biol. 104: 
761-767. 
24.  Hubbard, C., and R. J. Ivatt.  1981. Synthesis and processing of aspargine- 
linked oligosaccharides.  Annu.  Rev. Biochem.  50:555-583. 
25. Jacobs, S., F. C. KnlI, Jr., and P. Cuatrecasas.  1983. Monensin blocks the 
maturation of receptors for insulin and somatomedin C: identification of 
receptor precursors.  Proc. Natl. Acad.  Sci. USA. 80:1228-1231. 
26. John,  N. J., and G. L.  Firestone. 1986.  A sensitive two-step immunoad- 
sorption procedure to analyze the low abundance polypeptides by lower- 
ing nonspecific background.  Biotechniques,  4:404--406. 
27. John,  N.  J.,  D.  A.  Bravo,  O.  K.  Haffar,  and  G.  L.  Firestone.  1988. 
Glucocorticoid-dependent  complementation  of a bepatoma cell variant 
defective in viral glycoprotein sorting. Proc. Natl. Acad.  Sci. USA. 85: 
797-801. 
28. Juliano, R. L., and M. Behar-Bannelier. 1975. An evaluation of techniques 
for labeling the surface proteins of cultured mammalian cells. Biochim. 
Biophys. Acta.  375:249-267. 
29.  Karlsen, K., A. K. Vallerga, J. Hone, and G. L. Firestone.  1986. A distinct 
glucocorticoid hormone response regulates phosphoprotein maturation in 
rat hepatoma cells. Mol. Cell. Biol. 6:574-585. 
30.  Kelly,  R.  B.  1985. Pathway of protein  secretion  in eukaryotes.  Science 
(Wash. DC). 230:25-32. 
31. Komfeld,  R.,  and  S.  Kornfeld.  1985. Assembly  of  aspargine-linked 
oligosaccharides.  Annu.  Rev. Biochem.  54:631-664. 
32.  Krangel,  M.  S.,  H. T.  Orr, and J.  L.  Strominger.  1979. Assembly and 
maturation of HLA-A and HLA-B antigens in vivo.  Cell. 18:979-991. 
33. Kuismanen, E., J. Saraste, and R. F. Pettersson.  1985. Effect of monensin 
on the assembly of Uukuniemi virus in the Golgi complex. J.  Virol. 55: 
813-822. 
34.  Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly 
of the head of bacteria T4. Nature  (Lond.).  227:680-685. 
35.  Lodish, H. F., N. Kong, S. Hirani, and J. Rasmussen.  1987. A vesicular 
intermediate  in the transport  of hepatoma secretory  proteins  from the 
rough endoplasmic reticulum to the Golgi complex. J.  Cell Biol. 104: 
221-230. 
36.  Lodish, H. F., N. Kong, M. Snider, and G. J. A. M. Strous.  1983. Hepa- 
toma secretory proteins migrate from the rough endoplasmic reticulum 
to the Golgi at characteristic  rates. Nature (Loud.).  304:80-83. 
37.  Magee,  A.  I.,  and S.  A.  Courtneidge.  1985. Two classes of fatty acid 
acylated proteins exist in eukaryotic cells. EMBO  (Eur. Mol. Biol. Or- 
gan.) J.  4:1137-1144. 
38. Matlin, K., and K. Simons.  1984. Sorting of an apical plasma membrane 
glycoprotein occurs  before  it reaches the surface  in cultured  epithelial 
cells. J.  Cell Biol. 99:2131-2139 
39.  McDonald, K. 1984. Osmium  ferricyanide fixation improves microfilament 
preservation and membrane visualization in a variety of animal cell types. 
J.  Ultrastruct. Res. 86:107-118. 
40.  Mellman, I., R. Fuchs, and A. Helenius.  1986. Acidification of the endo- 
cytic and exocytic pathways. Annu. Rev. Biochem.  55:663-700. 
41.  Misek, D. E., E. Bard, and E. Rodriguez-Boulan.  1984. Biogenesis of epi- 
thelial cell polarity:  intracellular sorting and vectorial exocytosis of an 
apical plasma membrane glycoprotein.  Cell. 39:537-546. 
42.  O'Farrell,  P. H.  1975. High resolution two-dimensional electrophoresis of 
proteins. J.  Biol. Chem. 250:4007--4021. 
43.  Olson, E. N., and G. Spizz. 1986. Fatty acylation of cellular proteins: tem- 
poral and subcellular differences between palmitate and myristate acyla- 
tion. J.  Biol. Chem. 261:2458-2466. 
44.  Owen, M. J., A.-M.  Kissonerghis, and H. F.  Lodish.  1980. Biosynthesis 
of HLA-A and HLA-B antigens in vivo. J. Biol. Chem. 225:9678-9684. 
45.  Palade, G. E. 1975. Intracellular aspects of  the process of  protein secretion. 
Science (Wash. DC). 189:347-358. 
46.  Pfeiffer, S., S. D. Fuller,  and K. Simons.  1985. Intracellular sorting and 
basolateral appearance of the G protein of vesicular stomatitis virus in 
Madin-Darby canine kidney cells.  3.  Cell Biol. 101:470-476. 
47.  Platt, E. J., K. Karlsen, A. Lopez-Valdivieso, P. W. Cook, and G. L. Fire- 
stone. 1986. Highly sensitive immunoadsorption procedure for detection 
of low-abundance proteins.  Anal. Biochem. 156:126-135. 
48.  Presper, K. A., and E. C. Heath. 1985. Assembly, transfer and processing 
of  carbohydrate side chains of glycoproteins. In The Enzymology of Post- 
translational  Modifications of Proteins.  Vol.  2.  R.  B.  Freedman  and 
H. C.  Hawkins,  editors.  Academic Press Inc., N. Y. 53-93. 
49.  Pressman,  B. C.  1976. Biological applications of ionophores. Annu. Rev. 
Biochem.  45:501-530. 
50.  Ringold,  G.  M.,  P.  R.  Shank,  H.  E.  Varmus,  J.  Ring,  and  K.  R. 
Yamamoto.  1979. Integration and transcription  of mouse mammary tu- 
mor virus DNA in rat hepatoma cells. Proc. Natl. Acad. Sci. USA. 76: 
665 -669. 
51.  Rothman, J. E., and E. Fries.  1981. Transport of newly synthesized vesicu- 
lar  stomatitis viral  glycoprotein  to purified Golgi membranes.  J.  Cell 
Biol.  89:162-168. 
52.  Sabatini, D. D., G. Kreibich, T. Morimoto, and M. Adesnik. 1982. Mecha- 
nisms for the incorporation of proteins in membranes and organelles. J. 
Cell Biol. 92:1-22. 
53.  Saraste, J., and E. Kuismanen. 1984. Pre- and post-Golgi vacuoles operate 
Haffar et al. Regulated  Trafficking of Membrane Glycoproteins  1473 in the transport of Semliki Forest virus membrane glycoproteins to the 
cell surface.  Cell.  38:535-549. 
54. Sarkar,  N. H., and J.  Racevskis.  1983. Expression and disposition of the 
murine mammary tumor virus (MuMTV) envelope gene products by mu- 
rine mammary tumor cells.  Virology.  126:279-300. 
55.  Satake, M., and R. B. Lutwig. 1983. Comparative immunofluorescence of 
murine leukemia virus-derived membrane-associated antigens. Virology. 
124:259-273. 
56.  Schmidt, M. F. G., and M. J. Schlesinger.  1980. Relation of fatty acid at- 
tachment  to the translation  and maturation  of vesicular  stomatitis and 
sindbis virus membrane glycoproteins.  J. BioL  Chem.  255:3334-3339. 
57.  Sly, W.  S.,  and H. D. Fischer.  1982. The phosphomannosyl recognition 
system for intracellular transport of lysosomal enzymes. J. Cell Biochem. 
18:67-85. 
58. Tartakoff, A. M. 1983. Perturbation of vesicular traffic with the carboxylic 
ionophore monensin.  Celt.  32:1026-1028. 
59. Tartakoff, A., and P. Vassalli.  1978. Comparative studies of intracellular 
transport of secretory proteins.  J.  Cell Biol.  79:694-707. 
60. Townsend, L. E., and J. A. Benjamins. 1983. Effects of monensin on post- 
translational  processing  of myelin  proteins.  J.  Neurochem.  40:1333- 
1339. 
61.  Vega-Salas, D. E., P. J. I. Salas, and E. Rodriguez-Boulan. 1987. Modula- 
tion of the expression of an apical plasma membrane protein of Madin- 
Darby Canine Kidney epithelial cells:  cell-cell  interactions control the 
appearance of a novel intracellular  storage compartment.  J.  Cell Biol. 
104:1249-1259. 
62.  Walter, P., R. Gilmore, and G. Blobel.  1984. Protein translocation across 
the endoplasmic reticulum.  Cell.  38:5-8. 
63. Williams, D. B., S. J. Swiedler, and G. W. Hart.  1985. Intracellular trans- 
port of membrane glycoproteins:  two closely related histocompatibility 
antigens differ in their rates of transit to the cell surface. J. Cell Biol.  101 : 
725-734. 
64. Wold, F. 1981. In vivo chemical modification of proteins (posttranslational 
modification). Annu.  Rev.  Biochem.  50:783-814. 
65.  Yamamoto, K. R. 1985. Steroid receptor regulated transcription of specific 
genes and gene networks. Annu.  Rev.  Genet.  19:209-252. 
The Journal of Cell Biology, Volume  106, 1988  1474 